We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Intrepid Potash
IPI
$508M
| $1.09M | ﹤0.01% |
13,219
-1,315
| -9% | -$72.5K |
|
2102
Anika Therapeutics
ANIK
$277M
| $1.08M | ﹤0.01% |
43,056
+1,013
| +2% | +$30.9K |
|
2103
Amerant Bancorp
AMTB
$1.12B
| $1.08M | ﹤0.01% |
34,189
+142
| +0.4% | +$4.7K |
|
2104
Univest Financial
UVSP
$1.16B
| $1.08M | ﹤0.01% |
40,290
-3,500
| -8% | -$103K |
|
|
DENN
2105
DELISTED
Denny's
DENN
| $1.07M | ﹤0.01% |
74,958
-3,526
| -4% | -$53.7K |
|
2106
Carriage Services
CSV
$544M
| $1.07M | ﹤0.01% |
20,068
-3,241
| -14% | -$171K |
|
|
SUMO
2107
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $1.07M | ﹤0.01% |
91,587
+6,379
| +7% | +$73.9K |
|
|
TWOU
2108
DELISTED
2U Inc
TWOU
| $1.07M | ﹤0.01% |
2,678
+9
| +0.3% | +$3.62K |
|
2109
Gates Industrial Corporation Ltd.
GTES
$7.19B
| $1.06M | ﹤0.01% |
70,687
-9,929
| -12% | -$155K |
|
|
CPRX
2110
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.06M | ﹤0.01% |
127,953
-20,530
| -14% | -$145K |
|
2111
Horizon Bancorp
HBNC
$1.03B
| $1.05M | ﹤0.01% |
56,434
-4,973
| -8% | -$103K |
|
|
ZEUS
2112
DELISTED
Olympic Steel
ZEUS
| $1.05M | ﹤0.01% |
27,306
-95
| -0.3% | -$2.57K |
|
2113
Crinetics Pharmaceuticals
CRNX
$8.93B
| $1.05M | ﹤0.01% |
47,701
+4,654
| +11% | +$94.2K |
|
2114
Bally's
BALY
$637M
| $1.04M | ﹤0.01% |
33,981
+611
| +2% | +$20.6K |
|
|
BRY
2115
DELISTED
Berry Corp
BRY
| $1.04M | ﹤0.01% |
101,052
+6,115
| +6% | +$58K |
|
2116
PAR Technology
PAR
$751M
| $1.04M | ﹤0.01% |
25,784
+1,828
| +8% | +$74.9K |
|
2117
Cytek Biosciences
CTKB
$606M
| $1.04M | ﹤0.01% |
96,278
+81,455
| +550% | +$1.1M |
|
2118
Crescent Energy
CRGY
$4.03B
| $1.03M | ﹤0.01% |
59,591
+31,165
| +110% | +$461K |
|
2119
Inovio Pharmaceuticals
INO
$76.1M
| $1.03M | ﹤0.01% |
23,912
-2,487
| -9% | -$112K |
|
2120
Acco Brands
ACCO
$402M
| $1.02M | ﹤0.01% |
127,846
-19,884
| -13% | -$165K |
|
|
NPTN
2121
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.02M | ﹤0.01% |
67,215
-9,721
| -13% | -$148K |
|
2122
Driven Brands
DRVN
$2.07B
| $1.02M | ﹤0.01% |
38,765
-5,029
| -11% | -$146K |
|
2123
Lucid Motors
LCID
$2.6B
| $1.02M | ﹤0.01% |
4,013
-36
| -0.9% | -$10.7K |
|
2124
MBIA
MBI
$256M
| $1.02M | ﹤0.01% |
66,131
-28,192
| -30% | -$415K |
|
|
WOW
2125
DELISTED
WideOpenWest
WOW
| $1.01M | ﹤0.01% |
58,069
+2,074
| +4% | +$38.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.